Free Trial
NASDAQ:BMGL

Basel Medical Group (BMGL) Stock Price, News & Analysis

Basel Medical Group logo
$3.46 -1.24 (-26.38%)
As of 06/13/2025 04:00 PM Eastern

About Basel Medical Group Stock (NASDAQ:BMGL)

Key Stats

Today's Range
$2.93
$4.85
50-Day Range
$1.02
$5.09
52-Week Range
$0.91
$9.40
Volume
2.55 million shs
Average Volume
4.55 million shs
Market Capitalization
$63.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.

Receive BMGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Basel Medical Group and its competitors with MarketBeat's FREE daily newsletter.

BMGL Stock News Headlines

Basel Medical Group Ltd.
Utah’s New Oil Find
The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle of the Utah's Black Desert. Why? Not for oil discovery. Or uranium or solar. Instead, what’s happening beneath this patch of sand is the discovery of a new kind of energy. Google, Buffett, and a even tech billionaires like Gates, Bezos, and Zuckerberg are grabbing a stake.
BMGL Basel Medical Group Ltd
Basel Medical Group Ltd (BMGL)
See More Headlines

BMGL Stock Analysis - Frequently Asked Questions

Basel Medical Group's stock was trading at $4.50 on January 1st, 2025. Since then, BMGL stock has decreased by 23.1% and is now trading at $3.46.
View the best growth stocks for 2025 here
.

Basel Medical Group (BMGL) raised $9 million in an initial public offering on Tuesday, February 25th 2025. The company issued 2,205,000 shares at $4.00 per share.

Basel Medical Group's lock-up period expires on Monday, August 25th. Basel Medical Group had issued 2,205,000 shares in its public offering on February 25th. The total size of the offering was $8,820,000 based on an initial share price of $4.00. After the end of the company's lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted.

Shares of BMGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Services
Industry
Services – Health
Sub-Industry
Healthcare
Current Symbol
NASDAQ:BMGL
Web
N/A
Fax
N/A
Employees
36
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$10.05 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$63.85 million
Optionable
N/A
Beta
N/A
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:BMGL) was last updated on 6/15/2025 by MarketBeat.com Staff
From Our Partners